eszopiclone vs ramelteon
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of eszopiclone and ramelteon. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Lunesta
Rozerem
Eszopiclone (Lunesta) is a medicine that helps you fall asleep and stay asleep. It is used to treat insomnia.
Ramelteon (Rozerem) is a prescription medicine that can help you fall asleep faster. It works by acting like a natural hormone in your brain that regulates sleep.
Eszopiclone is used to treat insomnia, which means you have trouble falling asleep or staying asleep. It can help you fall asleep faster and stay asleep longer. Studies have shown it works for up to 6 months.
Ramelteon is used to treat insomnia when you have trouble falling asleep. It can help you fall asleep faster so you can get a better night's rest. Studies have shown it works for up to six months.
Eszopiclone works by slowing down activity in your brain. This helps you relax and fall asleep. It affects certain chemicals in your brain that regulate sleep.
Ramelteon works by targeting receptors in your brain that are involved in the sleep-wake cycle. It acts like melatonin, a hormone your body makes naturally to help you sleep. By binding to these receptors, ramelteon helps to promote sleepiness.
- • Unpleasant taste
- • Headache
- • Feeling sleepy
- • Respiratory infection
- • Dizziness
- • Feeling sleepy
- • Dizziness
- • Feeling tired
- • Nausea
- • Worsening insomnia
- Insomnia 3,888
- Dysgeusia 3,854
- Nausea 1,382
- Middle Insomnia 1,213
- Fatigue 1,185
- Initial Insomnia 447
- Somnolence 411
- Middle Insomnia 390
- Insomnia 388
- Nausea 327
Eszopiclone can cause complex sleep behaviors like sleepwalking, sleep driving, and doing other activities while not fully awake. Some of these can lead to serious injuries or even death. Stop taking eszopiclone right away if this happens.
Rarely, some people have had severe allergic reactions (angioedema and anaphylaxis) with throat closing, trouble breathing, nausea, or vomiting. If this happens, stop taking ramelteon and get medical help right away. Do not take ramelteon again if you've had this type of reaction to it. Ramelteon may cause changes in behavior, such as sleep-driving or hallucinations. It may also worsen depression or cause suicidal thoughts. Be careful driving or operating machinery, as ramelteon can affect your alertness.
It is not known if eszopiclone can harm your unborn baby. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Talk to your doctor if you are pregnant or plan to become pregnant. Animal studies suggest a risk of birth defects at high doses. It is not known if ramelteon passes into breast milk. Talk to your doctor about the risks and benefits of breastfeeding while taking this medicine, and watch for sleepiness or feeding problems in the baby.
Also Compare, Nearby Drugs
Compare eszopiclone with
Compare ramelteon with
How to Read This eszopiclone vs ramelteon Comparison
eszopiclone is classified in the Non-Benzodiazepine Hypnotic (Z-Drug) drug class, while ramelteon sits within the Melatonin Receptor Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, eszopiclone has 11,522 submissions while ramelteon has 1,963. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for eszopiclone or ramelteon.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.